Grever, M <br/><br/>
Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 1995 
 - 974-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1995.13.4.974  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Hemoglobins--metabolism<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Leukemia, Hairy Cell--drug therapy<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Pentostatin--therapeutic use<br/>Prospective Studies<br/>Recombinant Proteins<br/>Recurrence<br/>Remission Induction<br/>Splenomegaly--pathology<br/>United States